DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

« Back to Dashboard

Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

Docket		Date Filed	2014-09-03
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Mitchell S. Goldberg
Jury Demand	None	Referred To
Parties	ALEMBIC GLOBAL HOLDING S/A; ALEMBIC GLOBAL HOLDING SA; ALEMBIC PHARMACEUTICALS INC.; ALEMBIC PHARMACEUTICALS LTD.; ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED; AMNEAL PHARMACEUTICALS CO. INDIA PVT. LTD.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; BRECKENRIDGE PHARMACEUTICAL INC.; FOREST LABORATORIES HOLDINGS LTD.; FOREST LABORATORIES LLC; HIKMA PHARMACEUTICALS LLC; HIKMA PHARMACEUTICALS PLC; SIGMAPHARM LABORATORIES LLC; WEST-WARD PHARMACEUTICALS CORP.
Patents	4,371,516; 5,763,476; 7,741,358; 8,022,228
Attorneys	Aaron G. Clay; Aaron Gleaton Clay; Aiyda Ghahramani; Alton L. Hare , III; Anthony G. Simon; Anthony R. Friedman; Azy S. Kokabi; Benjamin R. Askew; Beth D. Jacob; Charles E. Lipsey; Christopher T. Griffith; Clifford E. Katz; David A. Bilson; Eve H. Ormerod; Helen H. Ji; Howard W. Levine; Imron T. Aly; Jack B. Blumenfeld; Jeffrey Thomas Castellano; Jennifer M. Rutter; Jeremy A. Tigan; Joel M. Wallace; John C. Phillips , Jr.; John E. Rosenquist; John K. Hsu; John Simon; Jonathan R. Davies; Karen Elizabeth Keller; Karen L. Pascale; Karen Shen; Ksenia Takhistova; Marc R. Wezowski; Maryellen Noreika; Megan C. Haney; Michael K. Levy; Michael P. Kella; Michael R. Dzwonczyk; Michael W. Glynn; Nathan Newbold; Neal C. Belgam; Nitya Anand; Paul M. Richter; Richard D. Kirk; Robert F. Green; Robert Karl Beste , III; Sanya Sukduang; Sara E. Bussiere; Seth R. Ogden; Stephen B. Brauerman; Steven J. Lee Ph.D.; Timothy D. Krieger; Vanessa Ribeiro Tiradentes
Firms	Bayard, P.A.; Gould & Ratner LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00			[PROPOSED] ORDEROF INFRINGEMENT OF U.S. PATENT NO. 5,763,476 BY ALEMBIC filed by Forest Laboratories …3 September 2014 1:14-cv-01119 830 Patent None District Court, D. Delaware	External link to document
0000-00-00	1		paragraphs 1-6. 8. United States Patent No. 5,763,476 (“the ’476 patent”), titled “Sublingual or Buccal…United States Patent No. 5,763,476 constitute infringement of one or more claims of said patent under 35 U.S.C…follows: a) declare that United States Patent Nos. 5,763,476 and 7,741,358 are valid; b) declare that…(A), Sigmapharm infringed United States Patent Nos. 5,763,476 and 7,741,358 by submitting ANDA No. 206107…than the expiration date of United States Patent Nos. 5,763,476 and 7,741,358, including any exclusivities	External link to document
0000-00-00	102		Infringement of Asserted Claims of U.S. Patent No. 5,763,476 by Amneal by Forest Laboratories Holdings…3 September 2014 1:14-cv-01119 830 Patent None District Court, D. Delaware	External link to document
0000-00-00	133		language of U.S. Patent Nos. 5,763,476, (the '476 patent), 7,741,358 (the '358 patent), and 8,022,228…treatments ... disclosed in U.S. Patent No. 4, 145,434 and 5,763,476." (D.I. 58, ex. 5, U.S. App.…claim 1 of the '228 patent which shares a specification with the '358 patent. All references in …8,022,228 (the '228 patent) shall be construed consistent with the tenets of claim construction set… The '476 Patent 1. "Tension, excitation, anxiety	External link to document